
1.13 Delayed Data As of Nov 30 | ![]() Today’s Change | 0.97 Today|||52-Week Range 3.50 | -41.45% Year-to-Date |
The 6 analysts offering 12-month price forecasts for Trevi Therapeutics Inc have a median target of 7.50, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a +563.72% increase from the last price of 1.13.
The current consensus among 6 polled investment analysts is to Buy stock in Trevi Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.